Uncategorized

New molecular target to improve neuroblastoma treatment

Anne Li                                           5/20/17

 

The annual mortality rate in childhood cancer of the sympathetic nervous system, or neuroblastoma, is 10 per million between the ages of 0 and 4. The collaborative work between Basque and Valencian researchers has served to identify some genetic mutations that will help to improve the treatment of this disease. Researchers at the Instituto de Investigación Sanitaria La Fe (Institute of Healthcare Research La Fe) in Valencia led by Jaime Font de Mora, in collaboration with José Luis Zugaza, an Ikerbasque researcher at the UPV/EHU-University of the Basque Country and the "Achucarro Basque Center for Neuroscience," have by means of NGS (Next Generation Sequencing) identified mutations in the Tiam1 gene that predict a better prognosis for neuroblastoma patients.

 

See original article at: https://www.sciencedaily.com/releases/2017/05/170519131645.htm

 

Comments(3)

  1. Lesskexia says

    Doxycycline Pills Black Market Amoxicilina Us Best Website Buy Now Tab Finasteride cialis 5 mg Cialis Bon Marche Differenze Cialis Viagra Propecia Crisis De Pelo

  2. StevAvaimb says

    Priligy Update Effets Cialis Generique Viagra On Line Senza Ricetta Buy Cialis Levitra 5mg Generique

  3. MatFeance says

    Amoxicillin Treatment Buy Cialis Kamagra Oral Jelly Cost Ou Trouver Priligy Pour Ligne Sans Prescription En Ligne Levitra 20mg Generique Prix

Post a comment